JP5808784B2 - 分配デバイス - Google Patents
分配デバイス Download PDFInfo
- Publication number
- JP5808784B2 JP5808784B2 JP2013207472A JP2013207472A JP5808784B2 JP 5808784 B2 JP5808784 B2 JP 5808784B2 JP 2013207472 A JP2013207472 A JP 2013207472A JP 2013207472 A JP2013207472 A JP 2013207472A JP 5808784 B2 JP5808784 B2 JP 5808784B2
- Authority
- JP
- Japan
- Prior art keywords
- fluid
- dispensing
- actuator mechanism
- housing
- sealing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000009826 distribution Methods 0.000 title claims description 35
- 230000007246 mechanism Effects 0.000 claims description 114
- 239000000463 material Substances 0.000 claims description 37
- 210000003928 nasal cavity Anatomy 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 3
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 2
- 229940088679 drug related substance Drugs 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 2
- 239000012530 fluid Substances 0.000 description 392
- 238000007789 sealing Methods 0.000 description 225
- 239000007788 liquid Substances 0.000 description 65
- -1 polypropylene Polymers 0.000 description 29
- 239000004743 Polypropylene Substances 0.000 description 22
- 210000003811 finger Anatomy 0.000 description 22
- 229920001155 polypropylene Polymers 0.000 description 22
- 239000003814 drug Substances 0.000 description 21
- 230000004048 modification Effects 0.000 description 21
- 238000012986 modification Methods 0.000 description 21
- 230000002093 peripheral effect Effects 0.000 description 21
- 229920003023 plastic Polymers 0.000 description 21
- 239000004033 plastic Substances 0.000 description 21
- 229940079593 drug Drugs 0.000 description 20
- 230000037452 priming Effects 0.000 description 20
- 210000002414 leg Anatomy 0.000 description 16
- 230000001681 protective effect Effects 0.000 description 15
- 239000011324 bead Substances 0.000 description 13
- 229920001684 low density polyethylene Polymers 0.000 description 11
- 239000004702 low-density polyethylene Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 238000004049 embossing Methods 0.000 description 10
- 239000007921 spray Substances 0.000 description 10
- 238000003780 insertion Methods 0.000 description 9
- 230000037431 insertion Effects 0.000 description 9
- 230000000295 complement effect Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 238000010304 firing Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000005086 pumping Methods 0.000 description 7
- 230000000284 resting effect Effects 0.000 description 7
- 238000004891 communication Methods 0.000 description 6
- 238000011049 filling Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 229920002725 thermoplastic elastomer Polymers 0.000 description 5
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000003862 glucocorticoid Substances 0.000 description 4
- 238000001746 injection moulding Methods 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 210000002105 tongue Anatomy 0.000 description 4
- 229920002943 EPDM rubber Polymers 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000012611 container material Substances 0.000 description 3
- 239000013583 drug formulation Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000003595 mist Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000000452 restraining effect Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000003199 leukotriene receptor blocking agent Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 206010039083 rhinitis Diseases 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920003031 santoprene Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- UBLVUWUKNHKCJJ-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;1,3-dimethyl-7h-purine-2,6-dione Chemical compound NCCCC[C@H](N)C(O)=O.O=C1N(C)C(=O)N(C)C2=C1NC=N2 UBLVUWUKNHKCJJ-ZSCHJXSPSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- PVXFCOPBOYHONF-UHFFFAOYSA-N 3-ethyl-1,3-benzothiazol-2-one Chemical compound C1=CC=C2SC(=O)N(CC)C2=C1 PVXFCOPBOYHONF-UHFFFAOYSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- JFHROPTYMMSOLG-UHFFFAOYSA-N 6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide Chemical compound COC1=CC=CC(NC=2C3=CC(=CC(C)=C3N=CC=2C(N)=O)S(=O)(=O)C=2C=C(C=CC=2)C(=O)N(C)C)=C1 JFHROPTYMMSOLG-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 108010059108 CD18 Antigens Proteins 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- IJVCSMSMFSCRME-KBQPJGBKSA-N Dihydromorphine Chemical compound O([C@H]1[C@H](CC[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O IJVCSMSMFSCRME-KBQPJGBKSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010041012 Integrin alpha4 Proteins 0.000 description 1
- HUYWAWARQUIQLE-UHFFFAOYSA-N Isoetharine Chemical compound CC(C)NC(CC)C(O)C1=CC=C(O)C(O)=C1 HUYWAWARQUIQLE-UHFFFAOYSA-N 0.000 description 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
- UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 description 1
- 206010028741 Nasal inflammation Diseases 0.000 description 1
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 1
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010039094 Rhinitis perennial Diseases 0.000 description 1
- 208000036284 Rhinitis seasonal Diseases 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 102000001400 Tryptase Human genes 0.000 description 1
- 108060005989 Tryptase Proteins 0.000 description 1
- YEEZWCHGZNKEEK-UHFFFAOYSA-N Zafirlukast Chemical compound COC1=CC(C(=O)NS(=O)(=O)C=2C(=CC=CC=2)C)=CC=C1CC(C1=C2)=CN(C)C1=CC=C2NC(=O)OC1CCCC1 YEEZWCHGZNKEEK-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960003728 ciclesonide Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 229940109248 cromoglycate Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 239000003602 elastase inhibitor Substances 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 229960000676 flunisolide Drugs 0.000 description 1
- 229960002714 fluticasone Drugs 0.000 description 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 description 1
- 229960001888 ipratropium Drugs 0.000 description 1
- 229960001268 isoetarine Drugs 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 229960004958 ketotifen Drugs 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 229960001664 mometasone Drugs 0.000 description 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 1
- 229960005127 montelukast Drugs 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229960004398 nedocromil Drugs 0.000 description 1
- RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical compound CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229960004708 noscapine Drugs 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 229960002657 orciprenaline Drugs 0.000 description 1
- NVOYVOBDTVTBDX-PMEUIYRNSA-N oxitropium Chemical compound CC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1 NVOYVOBDTVTBDX-PMEUIYRNSA-N 0.000 description 1
- 229960000797 oxitropium Drugs 0.000 description 1
- RLANKEDHRWMNRO-UHFFFAOYSA-M oxtriphylline Chemical compound C[N+](C)(C)CCO.O=C1N(C)C(=O)N(C)C2=C1[N-]C=N2 RLANKEDHRWMNRO-UHFFFAOYSA-M 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 1
- 229960004448 pentamidine Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 1
- 229960000395 phenylpropanolamine Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229960004583 pranlukast Drugs 0.000 description 1
- UAJUXJSXCLUTNU-UHFFFAOYSA-N pranlukast Chemical compound C=1C=C(OCCCCC=2C=CC=CC=2)C=CC=1C(=O)NC(C=1)=CC=C(C(C=2)=O)C=1OC=2C=1N=NNN=1 UAJUXJSXCLUTNU-UHFFFAOYSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960002720 reproterol Drugs 0.000 description 1
- WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229950004432 rofleponide Drugs 0.000 description 1
- IXTCZMJQGGONPY-XJAYAHQCSA-N rofleponide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O IXTCZMJQGGONPY-XJAYAHQCSA-N 0.000 description 1
- 229960002586 roflumilast Drugs 0.000 description 1
- MNDBXUUTURYVHR-UHFFFAOYSA-N roflumilast Chemical compound FC(F)OC1=CC=C(C(=O)NC=2C(=CN=CC=2Cl)Cl)C=C1OCC1CC1 MNDBXUUTURYVHR-UHFFFAOYSA-N 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000002750 tryptase inhibitor Substances 0.000 description 1
- 229950000339 xinafoate Drugs 0.000 description 1
- 229960004764 zafirlukast Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
- B05B1/34—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl
- B05B1/3405—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl to produce swirl
- B05B1/341—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl to produce swirl before discharging the liquid or other fluent material, e.g. in a swirl chamber upstream the spray outlet
- B05B1/3421—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl to produce swirl before discharging the liquid or other fluent material, e.g. in a swirl chamber upstream the spray outlet with channels emerging substantially tangentially in the swirl chamber
- B05B1/3431—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl to produce swirl before discharging the liquid or other fluent material, e.g. in a swirl chamber upstream the spray outlet with channels emerging substantially tangentially in the swirl chamber the channels being formed at the interface of cooperating elements, e.g. by means of grooves
- B05B1/3436—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl to produce swirl before discharging the liquid or other fluent material, e.g. in a swirl chamber upstream the spray outlet with channels emerging substantially tangentially in the swirl chamber the channels being formed at the interface of cooperating elements, e.g. by means of grooves the interface being a plane perpendicular to the outlet axis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/0005—Components or details
- B05B11/0037—Containers
- B05B11/0038—Inner container disposed in an outer shell or outer casing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/0005—Components or details
- B05B11/0062—Outlet valves actuated by the pressure of the fluid to be sprayed
- B05B11/0064—Lift valves
- B05B11/0067—Lift valves having a valve seat located downstream the valve element
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1001—Piston pumps
- B05B11/1004—Piston pumps comprising a movable cylinder and a stationary piston
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1001—Piston pumps
- B05B11/1016—Piston pumps the outlet valve having a valve seat located downstream a movable valve element controlled by a pressure actuated controlling element
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1038—Pressure accumulation pumps, i.e. pumps comprising a pressure accumulation chamber
- B05B11/104—Pressure accumulation pumps, i.e. pumps comprising a pressure accumulation chamber the outlet valve being opened by pressure after a defined accumulation stroke
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1042—Components or details
- B05B11/1043—Sealing or attachment arrangements between pump and container
- B05B11/1046—Sealing or attachment arrangements between pump and container the pump chamber being arranged substantially coaxially to the neck of the container
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1042—Components or details
- B05B11/1052—Actuation means
- B05B11/1056—Actuation means comprising rotatable or articulated levers
- B05B11/1057—Triggers, i.e. actuation means consisting of a single lever having one end rotating or pivoting around an axis or a hinge fixedly attached to the container, and another end directly actuated by the user
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1042—Components or details
- B05B11/1066—Pump inlet valves
- B05B11/107—Gate valves; Sliding valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1042—Components or details
- B05B11/1073—Springs
- B05B11/1074—Springs located outside pump chambers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Sampling And Sample Adjustment (AREA)
- Automatic Assembly (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Manipulator (AREA)
Description
図7〜21は、その動作の基本原理が、参照により本明細書に組み込むことのできるUS-A-2005/0236434及びWO-A-2005/075103に記載されているようなものであって、例えば液体中に懸濁又は溶解させた、薬剤を含有する定量の液体を分配するための、ポンプシステム(以下、「流体ディスペンサ110」)を示す。
Claims (49)
- 物質を分配するためのデバイスであって、
前記物質を分配可能な分配出口と、
第1の位置から第2の位置へと分配方向で移動するように装着された分配部材であって、使用の際、前記移動によって前記物質が前記分配出口から分配される、分配部材と、
前記分配部材を前記第1の位置から前記第2の位置へと移動させるアクチュエータ機構と、を有するデバイスにおいて、
前記アクチュエータ機構は、予め定められた方向で移動するように装着された第1の部材と、予め定められた枢動方向で枢動運動するように前記第1の部材上に枢動可能に装着された第2の部材と、を有し、
前記第1の部材が前記予め定められた方向へ移動するのにともなって前記第2の部材が移動して前記予め定められた枢動方向で枢動し、前記予め定められた枢動方向へ前記第2の部材が枢動運動することによって前記分配部材が前記第1の位置から前記第2の位置へと移動するように前記アクチュエータ機構が適合されており、
前記第1の部材の前記予め定められた方向での移動が、前記予め定められた枢動方向とは反対の方向での枢動運動であるデバイス。 - 前記分配部材が前記物質の供給源を含有する分配容器である、請求項1に記載のデバイス。
- 前記分配出口が前記分配方向と同軸で配置される、請求項1又は2に記載のデバイス。
- 前記アクチュエータ機構によって前記第1の位置から前記第2の位置へと前記分配部材が移動されるのに応答して、前記分配出口から前記物質の一回用量を送達するように適合された分配機構を、前記分配部材が備えている、請求項1から3のいずれか一項に記載のデバイス。
- 前記分配出口が、ヒト又は動物の身体の鼻腔に挿入されるようにサイズ及び形状が決められたノズル状である、請求項1から4のいずれか一項に記載のデバイス。
- 前記分配出口が、前記分配部材を中に受け入れるように適合されたハウジングの一部である、請求項1から5のいずれか一項に記載のデバイス。
- 前記第1の部材が指操作式アクチュエータ部材である、請求項1から6のいずれか一項に記載のデバイス。
- 前記指操作式アクチュエータ部材が単独のアクチュエータ部材である、請求項7に記載のデバイス。
- 前記第2の部材が剛性部材である、請求項1から8のいずれか一項に記載のデバイス。
- 前記予め定められた枢動方向で枢動すると前記分配部材の少なくとも一つの表面と接触して、前記分配部材を前記第1の位置から前記第2の位置へと移動させる、少なくとも一つの表面を前記第2の部材が有する、請求項1から9のいずれか一項に記載のデバイス。
- 使用の際に、前記第1の部材と、一方では前記第2の部材、他方ではプッシャー面との間の相対移動をもたらすように、前記アクチュエータ機構が適合され、前記相対移動によって前記プッシャー面が前記第2の部材と押圧係合されて、前記第2の部材を前記予め定められた枢動方向で枢動させる、請求項1から10のいずれか一項に記載のデバイス。
- 前記第1の部材が前記予め定められた方向で移動するにつれて、前記第2の部材を係合し、前記予め定められた枢動方向で前記第2の部材を枢動させるように適合されたプッシャー面を前記アクチュエータ機構が有する、請求項1から10のいずれか一項に記載のデバイス。
- 前記デバイスのハウジングによって前記プッシャー面が与えられる、請求項11又は12に記載のデバイス。
- 前記プッシャー面が前記デバイスの静止面である、請求項11から13のいずれか一項に記載のデバイス。
- 前記第2の部材がそこから延在する一対のアームを有する、請求項1から14のいずれか一項に記載のデバイス。
- 前記アームが異なる方向で延在する、請求項15に記載のデバイス。
- 前記アーム間に形成される角度が90°以下である、請求項16に記載のデバイス。
- 使用の際に、前記プッシャー面と係合して、前記予め定められた枢動方向で前記第2の部材を枢動させるように、前記第2の部材の前記アームの一つが適合される、請求項11から14のいずれか一項に従属する場合の請求項15から17のいずれか一項に記載のデバイス。
- 前記第2の部材の前記アームの一つが、前記第2の部材が前記予め定められた方向で枢動した際に前記分配部材を前記第1の位置から前記第2の位置へと運ぶキャリアアームである、請求項15から18のいずれか一項に記載のデバイス。
- 異なる長さの前記アームからなる、請求項15から19のいずれか一項に記載のデバイス。
- 前記第2の部材が前記アームの対を複数有する、請求項15から20のいずれか一項に記載のデバイス。
- 前記プッシャー面又は別のプッシャー面と係合して、前記予め定められた枢動方向での前記第2の部材の前記枢動移動をもたらすように適合された一つのアームを各アーム対が有する、請求項18に従属する場合の請求項21に記載のデバイス。
- 前記第2の部材がベルクランクである、請求項1から22のいずれか一項に記載のデバイス。
- 前記第2の部材を付勢して、前記予め定められた枢動方向とは反対の方向で枢動させる付勢力を、前記アクチュエータ機構が備える、請求項1から23のいずれか一項に記載のデバイス。
- 医薬物質を分配する請求項1から24のいずれか一項に記載のデバイス。
- 前記分配方向が軸線に沿っており、前記予め定められた方向が前記軸線をほぼ横断する、請求項1から25のいずれか一項に記載のデバイス。
- 前記予め定められた枢動方向が、前記軸線にほぼ垂直な枢動軸線を中心とする、請求項26に記載のデバイス。
- 分配デバイスを作動させるためのアクチュエータ機構であって、休止位置から動作位置へと移動するように前記デバイス内に装着可能な第1の部材と、
前記第1の部材上に枢動可能に装着される第2の部材と、
使用の際に、前記第1の部材が前記休止位置から前記動作位置へと移動するにつれて、前記第2の部材と協働して前記第2の部材を枢動させるように適合された表面と、を有する、アクチュエータ機構において、
使用の際に、前記第1の部材が前記休止位置から前記動作位置へ移動するのにともなって前記第2の部材が移動して前記第1の部材上で枢動するように適合されており、
前記第2の部材が前記表面と協働するとき、前記第2の部材の枢動方向とは反対の方向で枢動するように前記第1の部材を枢動可能に装着できるようになっているアクチュエータ機構。 - 前記第1の部材を前記デバイス内に枢動可能に装着することができる、請求項28に記載のアクチュエータ機構。
- 前記第1の部材をその上に装着可能な前記デバイスのハウジングによって前記表面が提供される、請求項28に記載のアクチュエータ機構。
- 作動位置へと移動されると物質を分配する前記デバイスの分配部材の表面又は分配部材と関連付けられる表面をさらに備え、前記第1の部材が前記休止位置から前記動作位置へと移動するにつれて、前記分配部材をその作動位置へと移動させるように、前記分配部材の前記表面又は前記分配部材と関連付けられる前記表面が前記第2の部材によって係合されるように適合された、請求項28から30のいずれか一項に記載のアクチュエータ機構。
- 前記表面が前記分配部材の構成部品によって提供される、請求項31に記載のアクチュエータ機構。
- 前記構成部品が前記分配部材の付属物である、請求項32に記載のアクチュエータ機構。
- 前記第1の部材がレバーである、請求項28から33のいずれか一項に記載のアクチュエータ機構。
- 前記第2の部材がクランクである、請求項28から34のいずれか一項に記載のアクチュエータ機構。
- 前記第2の部材が少なくとも一対のアームを有する、請求項28から35のいずれか一項に記載のアクチュエータ機構。
- 使用の際に、前記第1の部材がその休止位置からその動作位置へと移動するにつれて、前記デバイスの前記ハウジングの表面と協働して前記第2の部材を前記第1の部材上で枢動させるように適合された第1のアームと、使用の際に、前記第2の部材が前記第1の部材上で枢動するにつれて、前記分配部材が物質を分配するように、前記デバイスの分配部材をその作動位置へと移動させるように適合された第2のアームと、を前記少なくとも一対のアームが有する、請求項36に記載のアクチュエータ機構。
- 前記第2の部材を前記第1の部材に対して予め定められた枢動方向で付勢する付勢力をさらに含む、請求項28から37のいずれか一項に記載のアクチュエータ機構。
- ハウジングと、分配部材が物質を分配する作動後位置へと移動するように前記ハウジング内に装着される前記分配部材と、を備え、分配デバイスとともに使用するように適合された、請求項28から38のいずれか一項に記載のアクチュエータ機構。
- 指操作式である、請求項28から39のいずれか一項に記載のアクチュエータ機構。
- ばね要素を備える、請求項28から40のいずれか一項に記載のアクチュエータ機構。
- 前記ばね要素が前記第2の部材に含まれる、請求項41に記載のアクチュエータ機構。
- 前記ばね要素が前記第2の部材に一体に形成された部品である、請求項42に記載のアクチュエータ機構。
- 前記第1の部材に枢動可能に装着される前記第2の部材の装着区画上に前記ばね要素が配置される、請求項42又は43に記載のアクチュエータ機構。
- 請求項28から44のいずれか一項に記載の前記アクチュエータ機構を備える、分配デバイスのためのアクチュエータ。
- 前記第1の部材が装着されるハウジングを備える、請求項45に記載のアクチュエータ。
- 移動するように前記ハウジング内に前記第1の部材が装着されて、前記休止位置から前記動作位置へと移動する、請求項46に記載のアクチュエータ。
- 前記第1の部材が前記動作位置に向かって移動するにつれて、前記第2の部材と結合して、前記第2の部材を前記第1の部材上で枢動させるプッシャー面をさらに備える、請求項45から47のいずれか一項に記載のアクチュエータ。
- 別の第1の部材及び第2の部材を備える、請求項45から48のいずれか一項に記載のアクチュエータ。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0723418A GB0723418D0 (en) | 2007-11-29 | 2007-11-29 | A dispensing device |
GB0723418.0 | 2007-11-29 | ||
GB0809770.1 | 2008-05-29 | ||
GB0809770A GB0809770D0 (en) | 2008-05-29 | 2008-05-29 | A dispensing device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010535451A Division JP5427185B2 (ja) | 2007-11-29 | 2008-11-27 | 分配デバイス |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014050719A JP2014050719A (ja) | 2014-03-20 |
JP5808784B2 true JP5808784B2 (ja) | 2015-11-10 |
Family
ID=40304541
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010535451A Active JP5427185B2 (ja) | 2007-11-29 | 2008-11-27 | 分配デバイス |
JP2013207472A Active JP5808784B2 (ja) | 2007-11-29 | 2013-10-02 | 分配デバイス |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010535451A Active JP5427185B2 (ja) | 2007-11-29 | 2008-11-27 | 分配デバイス |
Country Status (18)
Country | Link |
---|---|
US (1) | US9050433B2 (ja) |
EP (2) | EP2222411B1 (ja) |
JP (2) | JP5427185B2 (ja) |
KR (2) | KR20150030780A (ja) |
CN (3) | CN104958827A (ja) |
AR (1) | AR069519A1 (ja) |
AU (1) | AU2008331300B2 (ja) |
BR (1) | BRPI0819454A2 (ja) |
CA (1) | CA2706791A1 (ja) |
CO (1) | CO6310972A2 (ja) |
ES (1) | ES2441809T3 (ja) |
HK (1) | HK1142028A1 (ja) |
IL (2) | IL205908A (ja) |
MX (1) | MX2010005924A (ja) |
RU (2) | RU2491998C2 (ja) |
TW (2) | TW201513903A (ja) |
WO (1) | WO2009068877A1 (ja) |
ZA (1) | ZA201406809B (ja) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104958827A (zh) | 2007-11-29 | 2015-10-07 | 葛兰素集团有限公司 | 配给设备 |
FR2929252B1 (fr) * | 2008-03-27 | 2012-02-03 | Rexam Pharma La Verpilliere | Dispositif de distribution de fluide comprenant une pompe |
FR2932399B1 (fr) * | 2008-06-17 | 2011-10-28 | Valois Sas | Dispositif de distribution de produit fluide |
FR2963329B1 (fr) * | 2010-07-30 | 2013-06-28 | Thea Lab | Tete de distribution d'un liquide goutte a goutte |
FR2973011B1 (fr) * | 2011-03-21 | 2013-04-26 | Valois Sas | Dispositif de distribution de produit fluide a actionnement lateral. |
FR2973010B1 (fr) * | 2011-03-21 | 2013-04-26 | Valois Sas | Dispositif de distribution de produit fluide a actionnement lateral. |
FR2973013B1 (fr) * | 2011-03-21 | 2014-06-06 | Valois Sas | Dispositif de distribution de produit fluide a actionnement lateral. |
FR2973014B1 (fr) * | 2011-03-21 | 2014-06-06 | Valois Sas | Dispositif de distribution de produit fluide a actionnement lateral. |
FR2973012B1 (fr) * | 2011-03-21 | 2013-04-26 | Valois Sas | Dispositif de distribution de produit fluide a actionnement lateral. |
FR2973015B1 (fr) * | 2011-03-25 | 2013-04-26 | Valois Sas | Pompe de distribution de produit fluide. |
JP5707236B2 (ja) * | 2011-05-31 | 2015-04-22 | 株式会社吉野工業所 | 吐出容器 |
US8646659B2 (en) * | 2011-08-24 | 2014-02-11 | Calibre Closures Llc | Dispensing container for dispensing predetermined amounts of product |
EP2583757A1 (en) | 2011-10-17 | 2013-04-24 | LEK Pharmaceuticals d.d. | Manually operable fluid dispensing device |
EP2583758A1 (en) | 2011-10-17 | 2013-04-24 | LEK Pharmaceuticals d.d. | Manually operable fluid dispensing device |
EP2771051B1 (en) | 2011-10-27 | 2018-07-04 | Victor Esteve | Medicine dispensing device |
RU2640008C2 (ru) | 2012-02-24 | 2017-12-25 | Оптиноуз Ас | Назальное устройство подачи вещества |
US20150165138A1 (en) * | 2012-07-31 | 2015-06-18 | Sanofi Sa | Arrangement for a Drug Delivery Device |
DE102012025414A1 (de) * | 2012-12-20 | 2014-06-26 | Meadwestvaco Calmar Gmbh | Manuell betätigbarer Spender für Medien |
WO2014134275A2 (en) | 2013-02-27 | 2014-09-04 | The George Washington University | Ultrasound assisted catheter placement system |
KR200476949Y1 (ko) * | 2013-08-22 | 2015-04-20 | 펌텍코리아 (주) | 두 가지 내용물을 보관, 배출할 수 있는 화장품용기 |
KR102118150B1 (ko) * | 2013-11-25 | 2020-06-02 | 주식회사 엘지생활건강 | 작동 레버를 구비한 화장품 용기 |
US9205167B2 (en) * | 2014-05-02 | 2015-12-08 | Kimberly-Clark Worldwide, Inc. | Dispenser system for aerosol and non-aerosol products |
JP6322844B2 (ja) | 2014-06-25 | 2018-05-16 | 東興薬品工業株式会社 | 医療用シリンジに用いられる点鼻用噴霧ノズル |
LT3162378T (lt) | 2014-06-25 | 2024-03-12 | Toko Yakuhin Kogyo Kabushiki Kaisha | Gripo vakcinos nazalinė vakcinacijos sistema |
WO2016058124A1 (en) * | 2014-10-14 | 2016-04-21 | The Procter & Gamble Company | Dispensing article having piston with indicium |
DE202015004852U1 (de) * | 2015-07-06 | 2016-10-13 | 5med GmbH | Nasenapplikator |
TWI634816B (zh) * | 2016-03-01 | 2018-09-01 | 景碩科技股份有限公司 | Easy to test multilayer board |
US9967975B2 (en) | 2016-04-29 | 2018-05-08 | Kinsus Interconnect Technology Corp. | Multi-layer circuit board |
US10301057B2 (en) | 2016-07-11 | 2019-05-28 | Calibre Closures Llc | Dispensing container with internal squeeze limiting member |
WO2018083257A1 (en) | 2016-11-03 | 2018-05-11 | Psioxus Therapeutics Limited | Oncolytic adenovirus encoding transgenes |
WO2018083258A1 (en) | 2016-11-03 | 2018-05-11 | Psioxus Therapeutics Limited | Oncolytic adenovirus encoding at least three transgenes |
CN109311036B (zh) * | 2016-11-06 | 2022-06-07 | 微邦科技股份有限公司 | 微结构喷嘴 |
EP3538196A1 (en) * | 2016-11-08 | 2019-09-18 | Medical Brands Research B.V. | Applicator device |
EA038326B1 (ru) * | 2016-12-13 | 2021-08-10 | Медикал Брэндс Рисерч Б.В. | Аппликационное устройство |
EP3378569A1 (en) | 2017-03-21 | 2018-09-26 | The Procter & Gamble Company | Dispensing device |
DK3630143T3 (da) | 2017-06-01 | 2023-08-14 | Akamis Bio Ltd | Onkolytisk virus og fremgangsmåde |
EP3450351A1 (en) * | 2017-09-01 | 2019-03-06 | The Procter & Gamble Company | Apparatus and method for dispensing a metered dose of a product |
US20200009081A1 (en) * | 2017-09-13 | 2020-01-09 | Janssen Pharmaceutica N.V. | Delivery Of Esketamine For The Treatment Of Depression |
EP3489171A1 (en) | 2017-11-23 | 2019-05-29 | The Procter & Gamble Company | Piston with flexible closure for aerosol container |
EP3513880B1 (en) | 2018-01-23 | 2021-08-25 | The Procter & Gamble Company | Dispensing device suitable for a foamable product |
FR3082442B1 (fr) * | 2018-06-13 | 2021-04-09 | Aptar France Sas | Dispositif de distribution de produit fluide |
US11267644B2 (en) | 2018-11-08 | 2022-03-08 | The Procter And Gamble Company | Aerosol foam dispenser and methods for delivering a textured foam product |
US10850914B2 (en) | 2018-11-08 | 2020-12-01 | The Procter And Gamble Company | Dip tube aerosol dispenser with upright actuator |
LT3738677T (lt) * | 2019-05-16 | 2022-02-25 | Brill Engines, S.L. | Skystųjų medžiagų dozavimui tinkamas įtaisas |
CA3146037A1 (en) * | 2019-08-08 | 2021-02-11 | Jt International Sa | Aerosol generation device |
USD948028S1 (en) * | 2019-09-25 | 2022-04-05 | Aptar France Sas | Nasal spray device |
USD935011S1 (en) * | 2019-09-25 | 2021-11-02 | Aptar France Sas | Nasal spray device |
USD947359S1 (en) * | 2019-09-25 | 2022-03-29 | Aptar France Sas | Nasal spray device |
FR3106765B1 (fr) * | 2020-02-04 | 2022-12-30 | Eveon | Buse de pulvérisation de liquide sous forme de brouillard |
CN113679910A (zh) * | 2020-05-19 | 2021-11-23 | 顾瑜 | 雾化装置 |
USD1010101S1 (en) | 2020-09-18 | 2024-01-02 | Trudell Medical International | Holding chamber |
IT202000027618A1 (it) * | 2020-11-18 | 2022-05-18 | Lumson Spa | Dispositivo di erogazione di una sostanza fluida |
US11493295B1 (en) | 2021-07-08 | 2022-11-08 | Charles L. Broadnax | Tamper-actuated fluid release firearm interlock |
WO2023141308A1 (en) * | 2022-01-22 | 2023-07-27 | Tarrats Luisam | Nasal irrigation device |
CN114863856A (zh) * | 2022-04-25 | 2022-08-05 | 武汉天马微电子有限公司 | 显示面板的驱动方法、显示装置 |
EP4338774A1 (de) * | 2022-09-16 | 2024-03-20 | Aptar Radolfzell GmbH | Austragkopf für einen flüssigkeitsspender sowie flüssigkeitsspender mit einem solchen austragkopf |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB659132A (en) | 1949-04-19 | 1951-10-17 | Rotherham & Sons Ltd | Squirting or spraying devices |
US3405843A (en) * | 1966-11-23 | 1968-10-15 | Cornelius B. Watson Jr. | Container-dispenser for collapsible tubes |
US4710178A (en) | 1982-11-03 | 1987-12-01 | Micro-Mega S.A. | Precision injection system and method for intraligmental anesthesia |
EP0109913A3 (fr) | 1982-11-03 | 1984-09-12 | Micro-Mega | Seringue dentaire pour injections intra-ligamentaires |
US4771769A (en) | 1982-12-20 | 1988-09-20 | Schering Corporation | Hand held metered spray dispenser |
US4623337A (en) * | 1984-03-08 | 1986-11-18 | Alpha Group, Inc. | Liquid dispensing apparatus |
DE3722469A1 (de) | 1987-07-08 | 1989-01-19 | Pfeiffer Erich Gmbh & Co Kg | Handbetaetigbare austragvorrichtung fuer medien |
FR2631320B1 (fr) | 1988-05-10 | 1990-11-30 | Oreal | Recipient pressurise comportant une valve et un dispositif d'actionnement de la valve |
US5514365A (en) | 1988-10-11 | 1996-05-07 | Schiapparelli Salute S.P.A. | Pharmaceutical compositions comprising calcitonin for intranasal administration |
IL91856A0 (en) | 1988-10-11 | 1990-06-10 | Schiapparelli Salute Spa | Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same |
FR2637870B1 (fr) | 1988-10-13 | 1990-12-28 | Oreal | Recipient pressurise comportant un systeme de blocage de la valve lorsque le recipient n'est pas en position convenable |
GB2243880B (en) | 1990-05-01 | 1994-03-16 | Bespak Plc | Dispensing device |
JPH0639808Y2 (ja) * | 1990-09-19 | 1994-10-19 | 小池化学株式会社 | 噴霧具 |
FR2671294A1 (fr) | 1991-01-09 | 1992-07-10 | Savona Jean Louis | Boitier rechargeable pour support de bombe anti-agression a gaz paralysant colore pour marquage et identification de l'agresseur. |
RU2093236C1 (ru) | 1992-03-31 | 1997-10-20 | Калининградский государственный технический университет | Двухступенчатый пленочный испаритель |
US5377869A (en) | 1992-08-27 | 1995-01-03 | Weiss; Stephan | Pump dispenser with movable bottle |
RU2093276C1 (ru) | 1995-04-28 | 1997-10-20 | Виталий Федорович Уткин | Устройство для распыления жидкости |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
DE19610456B4 (de) | 1996-03-16 | 2006-10-19 | Ing. Erich Pfeiffer Gmbh | Austragvorrichtung für Medien |
JPH10179739A (ja) * | 1996-10-31 | 1998-07-07 | Taisei Kako Kk | 液体吐出容器 |
US6033384A (en) | 1997-12-18 | 2000-03-07 | Py; Daniel | One-way actuation release mechanism for a system for applying medicament |
DE19756442A1 (de) | 1997-12-18 | 1999-06-24 | Pfeiffer Erich Gmbh & Co Kg | Spender für Medien |
SE9801078D0 (sv) * | 1998-03-27 | 1998-03-27 | Shl Medical Ab | Inhalator |
SE9902672D0 (sv) * | 1999-07-12 | 1999-07-12 | Astra Ab | Delivery device |
JP4056740B2 (ja) | 1999-10-16 | 2008-03-05 | グラクソ グループ リミテッド | エアゾール容器のための装置のハウジング |
US6302101B1 (en) * | 1999-12-14 | 2001-10-16 | Daniel Py | System and method for application of medicament into the nasal passage |
US6173868B1 (en) | 2000-03-08 | 2001-01-16 | Calmar Inc. | Nasal sprayer with folding actuator |
DE10032976A1 (de) | 2000-07-06 | 2002-01-17 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
FR2812826B1 (fr) * | 2000-08-11 | 2003-04-18 | Valois Sa | Dispositif de pulverisation a actionnement lateral, en particulier poussoir nasal |
FR2813592B1 (fr) | 2000-09-07 | 2003-03-21 | Valois Sa | Dispositif de distribution de produit fluide du type monodose ou bidose |
FR2813593B1 (fr) | 2000-09-07 | 2002-12-06 | Valois Sa | Dispositif de distribution de produit fluide de type multidose |
US6338422B1 (en) | 2000-10-11 | 2002-01-15 | Saint-Gobain Calmar Inc. | Actuation device for manually operated pump sprayer |
US7331944B2 (en) * | 2000-10-23 | 2008-02-19 | Medical Instill Technologies, Inc. | Ophthalmic dispenser and associated method |
SE0004751D0 (sv) | 2000-12-19 | 2000-12-19 | Astrazeneca Ab | A delivery device |
SE0100034D0 (sv) | 2001-01-04 | 2001-01-04 | Astrazeneca Ab | A delivery device |
US6745760B2 (en) * | 2001-05-15 | 2004-06-08 | Trudell Medical International | Medicament applicator |
FR2830519B1 (fr) | 2001-10-04 | 2004-08-27 | Valois Sa | Dispositif de distribution de produit fluide a actionnement lateral |
FR2830522B1 (fr) | 2001-10-04 | 2004-02-13 | Tebro | Dispositif de distribution de produit fluide a actionnement lateral |
FR2832329B1 (fr) | 2001-11-20 | 2004-11-19 | Valois Sa | Dispositif de pulverisation a actionnement lateral |
FR2834920B1 (fr) * | 2002-01-22 | 2004-04-09 | Valois Sa | Dispositif de pulverisation a actionnement lateral |
JP4019309B2 (ja) | 2002-02-28 | 2007-12-12 | 株式会社吉野工業所 | 注出容器 |
US7484642B2 (en) | 2002-08-06 | 2009-02-03 | Glaxo Group Limited | Dispenser |
EP1536894B1 (de) | 2002-09-05 | 2011-03-30 | Boehringer Ingelheim Pharma GmbH & Co.KG | Apparat zum ausbringen von fluessigkeiten, hierzu geeignete behaelterpatrone, und system aus dem apparat zum ausbringen von fluessigkeiten und der behaelterpatrone |
US7699052B2 (en) | 2002-09-05 | 2010-04-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Apparatus for the dispensing of liquids, container cartridge suitable for this, and system comprising the apparatus for the dispensing of liquids, and the container cartridge |
US7070071B2 (en) | 2002-09-23 | 2006-07-04 | Agouron Pharmaceuticals, Inc. | Dispensing apparatus and method for liquid products, particularly medicinal products |
SE0202800D0 (sv) | 2002-09-23 | 2002-09-23 | Pharmacia Ab | Dispensing apparatus and method for liquid products, particularly medicinal products |
FR2847889B1 (fr) | 2002-11-29 | 2005-03-04 | Dispositif de distribution de produit fluide | |
GB0301366D0 (en) | 2003-01-21 | 2003-02-19 | Glaxo Group Ltd | A fixation device |
US20040188473A1 (en) | 2003-03-25 | 2004-09-30 | Groh David M. | Hand-held product dispensers having pressurized delivery |
FR2854821B1 (fr) * | 2003-05-16 | 2006-12-08 | Oreal | Ensemble pour le conditionnement et la distribution d'un produit, notamment sous forme d'un echantillon |
FR2859464B1 (fr) | 2003-09-09 | 2005-11-11 | Techniplast | Dispositif de distribution a pompe pour un produit fluide, liquide ou pateux |
BRPI0416128B8 (pt) * | 2003-11-03 | 2021-06-22 | Glaxo Group Ltd | dispositivo de dispensação de fluido |
GB0405477D0 (en) | 2004-03-11 | 2004-04-21 | Glaxo Group Ltd | A fluid dispensing device |
GB0402695D0 (en) * | 2004-02-06 | 2004-03-10 | Glaxo Group Ltd | A metering pump system |
GB0402692D0 (en) * | 2004-02-06 | 2004-03-10 | Glaxo Group Ltd | A fluid dispenser |
GB0402690D0 (en) | 2004-02-06 | 2004-03-10 | Glaxo Group Ltd | A fluid dispenser |
FR2882349B1 (fr) | 2005-02-21 | 2007-05-25 | Tebro Sa Luxembourgeoise | Tete de distribution de produit fluide. |
FR2889691B1 (fr) | 2005-08-11 | 2010-11-12 | Marc Hemon | Dispositif de distribution d'un produit fluide sous forme de goutte |
FR2889692B1 (fr) | 2005-08-11 | 2010-09-03 | Techniplast | Dispositif de distribution d'un produit fluide |
GB0610666D0 (en) | 2006-05-30 | 2006-07-05 | Glaxo Group Ltd | Fluid dispenser |
EP1974828B1 (de) | 2007-03-26 | 2010-11-03 | Ing. Erich Pfeiffer GmbH | Austragvorrichtung für Medien |
DE102007016503A1 (de) | 2007-03-26 | 2008-10-02 | Ing. Erich Pfeiffer Gmbh | Austragvorrichtung für Medien |
SG2014009625A (en) | 2007-05-30 | 2014-05-29 | Glaxo Group Ltd | Fluid dispenser |
JP4942622B2 (ja) | 2007-11-28 | 2012-05-30 | 花王株式会社 | ストッパー付ポンプ容器 |
CN104958827A (zh) | 2007-11-29 | 2015-10-07 | 葛兰素集团有限公司 | 配给设备 |
FR2929252B1 (fr) | 2008-03-27 | 2012-02-03 | Rexam Pharma La Verpilliere | Dispositif de distribution de fluide comprenant une pompe |
FR2931137B1 (fr) | 2008-05-13 | 2012-03-30 | Valois Sas | Dispositif de distribution de produit fluide |
FR2932400B1 (fr) | 2008-06-17 | 2011-11-18 | Valois Sas | Dispositif de distribution de produit fluide |
FR2932399B1 (fr) * | 2008-06-17 | 2011-10-28 | Valois Sas | Dispositif de distribution de produit fluide |
-
2008
- 2008-11-27 CN CN201510068332.8A patent/CN104958827A/zh active Pending
- 2008-11-27 US US12/745,298 patent/US9050433B2/en active Active
- 2008-11-27 AU AU2008331300A patent/AU2008331300B2/en not_active Ceased
- 2008-11-27 CA CA2706791A patent/CA2706791A1/en not_active Abandoned
- 2008-11-27 TW TW103142038A patent/TW201513903A/zh unknown
- 2008-11-27 EP EP08854185.9A patent/EP2222411B1/en active Active
- 2008-11-27 RU RU2010121234/05A patent/RU2491998C2/ru not_active IP Right Cessation
- 2008-11-27 KR KR20157005510A patent/KR20150030780A/ko not_active Application Discontinuation
- 2008-11-27 CN CN201410661431.2A patent/CN104353162A/zh active Pending
- 2008-11-27 TW TW097146079A patent/TWI519327B/zh not_active IP Right Cessation
- 2008-11-27 JP JP2010535451A patent/JP5427185B2/ja active Active
- 2008-11-27 BR BRPI0819454 patent/BRPI0819454A2/pt not_active IP Right Cessation
- 2008-11-27 MX MX2010005924A patent/MX2010005924A/es active IP Right Grant
- 2008-11-27 CN CN200880125859.8A patent/CN102186598B/zh not_active Expired - Fee Related
- 2008-11-27 EP EP13187273.1A patent/EP2730340B1/en active Active
- 2008-11-27 WO PCT/GB2008/003954 patent/WO2009068877A1/en active Application Filing
- 2008-11-27 KR KR1020107014408A patent/KR101526843B1/ko not_active IP Right Cessation
- 2008-11-27 ES ES08854185.9T patent/ES2441809T3/es active Active
- 2008-12-01 AR ARP080105235A patent/AR069519A1/es not_active Application Discontinuation
-
2010
- 2010-05-23 IL IL205908A patent/IL205908A/en not_active IP Right Cessation
- 2010-06-23 CO CO10075824A patent/CO6310972A2/es active IP Right Grant
- 2010-09-02 HK HK10108339.1A patent/HK1142028A1/xx not_active IP Right Cessation
-
2013
- 2013-05-06 RU RU2013121779/14A patent/RU2013121779A/ru not_active Application Discontinuation
- 2013-10-02 JP JP2013207472A patent/JP5808784B2/ja active Active
-
2014
- 2014-09-17 ZA ZA2014/06809A patent/ZA201406809B/en unknown
- 2014-10-28 IL IL235365A patent/IL235365A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5808784B2 (ja) | 分配デバイス | |
JP5744515B2 (ja) | 流体ディスペンサ | |
EP2029287B1 (en) | Fluid dispenser | |
AU2013267071A1 (en) | A dispensing device | |
AU2013263698A1 (en) | Fluid dispenser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140801 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140805 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20141030 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20141105 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150204 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150825 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150909 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5808784 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |